BioSpace News Archive

Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - Further to the press release of Psygen Industries Ltd. (“Psygen”) and Larose Ventures Ltd. dated March 24, 2021, Psygen and 1290442 B.C. Ltd.

Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular embolization, announced that the first patient has been enrolled in the LAVA Study to evaluate the safety and effectiveness of the BlackSwan Lava™ liquid embolic system

Each Over-Allotment Unit consists of one common share in the capital of the Company (each, a “Unit Share”) and one common share purchase warrant of the Company (each, a “Warrant”).

Retractable Technologies, Inc. (NYSE American: RVP) announced today that, in accordance with the 30 day notice requirement, it received a preliminary notice from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness & Response (“HHS/ASPR”) expressing its intent to exercise at least the first two one-month options under the February 2021 contract between HHS/ASPR and Retractable

Pyxis Oncology (“Pyxis” or the “Company”) today announced that it will host a key opinion leader (KOL) webinar on antibody-drug conjugates on Tuesday, April 27, 2021 at 1pm Eastern Time.

Advanced Human Imaging Limited (ASX: AHI) (“AHI” or the “Company”) is pleased to announce that it has signed a Letter of Intent (LOI) for the proposed acquisition of Israeli-based musculoskeletal assessment company Physimax Technologies Limited (Physimax).

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the results of an animal study model for MMS019, its anti-viral product candidate for respiratory viruses.

GSK Consumer Healthcare, the maker of Advil, announced its commitment to reducing the plastic in over 80 million Advil bottles1 by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment.

New Data Presented at 2021 American Academy of Neurology (AAN) Annual Meeting Shows VYEPTI® (eptinezumab-jjmr) Demonstrated Earlier Time to Freedom from Headache Pain and Absence of Most Bothersome Symptoms Compared to Placebo When Initiated During Migraine Attack in Patients Who Were Candidates for Preventive Therapy

As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entered into an agreement with Abbott to sell the BinaxNOW™ Rapid Antigen Self Test over-the-counter in Walgreens stores nationwide